Skip to content

Effect of summer-acupoint-application-therapy (SAAT) on reducing exacerbation frequency of Chronic Lung Diseases in winter

Effect of summer-acupoint-application-therapy (SAAT) on reducing exacerbation frequency of Chronic Lung Diseases in winter

Status
Active, not recruiting
Phases
Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OCH-11001292
Enrollment
Unknown
Registered
2011-04-08
Start date
2008-07-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Lung Diseases, including bronchial asthma, COPD, chronic bronchitis, allergic rhinitis and RRTL

Interventions

Group B:SAAT II
Group C:SAAT III
Group D:SAAT IV
Total:SAAT IV
Group A:SAAT I

Sponsors

Institute of Basic Research In Clinical Medicine, China Academy of Chinese Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
2 Years to No maximum

Inclusion criteria

Inclusion criteria: 1) have been diagnosed bronchial asthma, COPD, chronic bronchitis, allergic rhinitis, RRTL; 2)with a history of frequent exacerbation (more than twice per year); 3)aged 2-y and above; 4) willing to participate

Exclusion criteria

Exclusion criteria: 1)have no episodes of exacerbation in recent year; 2) are during pregnancy or lactation; 3) are allergic to herbs in SAAT; 4) are suffering from high fever; 5) are suffering from other lung disease except the five above; 6)are suffering from acute cardiac or liver or kidney disease, mental disease, or malignancy

Design outcomes

Primary

MeasureTime frame
ratio of exacerbation dicrease;frequency of diseases exacerbation;severity of diseases exacerbation;

Countries

China

Contacts

Public ContactJin Peng
pengjin2000@163.com+86 010 64014411-3310

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026